Associations Between Leisure-Time Physical Activity and Metabolomics-Based Markers of Biological Aging in Late Midlife: Short-Term and Long-Term Follow-Up

被引:0
|
作者
Ruutu, Katri [1 ,2 ]
Wasenius, Niko S. [1 ,3 ,4 ]
Narasimhan, Kothandaraman [5 ]
Mikkola, Tuija M. [1 ,6 ,7 ]
Laine, Merja K. [1 ,3 ,4 ]
Eriksson, Johan G. [1 ,5 ,8 ]
机构
[1] Folkhalsan Res Ctr, Helsinki, Finland
[2] Univ Helsinki, Fac Med, Helsinki, Finland
[3] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Agcy Sci Technol & Res, Inst Human Dev & Potential, Singapore City, Singapore
[6] Finnish Inst Hlth & Welf, Populat Hlth Unit, Helsinki, Finland
[7] Univ Helsinki, Fac Med, Clinicum, Helsinki, Finland
[8] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore City, Singapore
关键词
accelerometer-based physical activity; biological aging; leisure-time physical activity; metabolic aging; metabolomics; MAGNETIC-RESONANCE METABOLOMICS; EPIDEMIOLOGY; RISK; AGE;
D O I
10.1111/acel.70033
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Physical activity (PA) may delay the onset of age-related diseases by decelerating biological aging. We investigated the association between leisure-time physical activity (LTPA) and metabolomics-based aging markers (MetaboAge and MetaboHealth) in late midlife and during 16 years of follow-up. At the 16-year follow-up, we also investigated the association between device-based PA and MetaboAge and MetaboHealth. We included 1816 individuals (mean age 61.6 years) from the Helsinki Birth Cohort Study at baseline and followed them up for 5 (n = 982) and 16 years (n = 744), respectively. LTPA was assessed via questionnaire at baseline and 16 years later and device-based PA with ActiGraph accelerometer at the 16-year follow-up. Fasting blood samples were applied to calculate MetaboAge acceleration (Delta metaboAge) and MetaboHealth at baseline and at both follow-ups. Covariate-adjusted multiple regression analyses and linear mixed models were applied to study the associations. A higher volume of LTPA at baseline was associated with a lower MetaboHealth score at the 5-year follow-up (p < 0.0001 for time x LTPA interaction). No associations were detected at the 16-year follow-up. An increase in LTPA over 16 years was associated with a decrease in MetaboHealth score (p < 0.001) and a decrease in LTPA with an increase in MetaboHealth score. Higher device-based PA was associated with a lower MetaboHealth score, but not with Delta metaboAge. In conclusion, higher LTPA in late midlife and device-based PA in old age were associated with improved MetaboHealth. Increasing LTPA with age may protect against MetaboHealth-based aging. The results support the importance of PA for biological aging in later life.
引用
收藏
页数:13
相关论文
共 50 条